General Information of Drug Off-Target (DOT) (ID: OTB2X9TO)

DOT Name Probable ATP-dependent RNA helicase DDX46 (DDX46)
Synonyms EC 3.6.4.13; DEAD box protein 46; PRP5 homolog
Gene Name DDX46
Related Disease
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 ( )
Amyotrophic lateral sclerosis type 4 ( )
Colorectal carcinoma ( )
Connective tissue disorder ( )
Esophageal squamous cell carcinoma ( )
Hepatitis C virus infection ( )
Juvenile amyotrophic lateral sclerosis ( )
Systemic lupus erythematosus ( )
Werner syndrome ( )
Small lymphocytic lymphoma ( )
Systemic sclerosis ( )
Bone osteosarcoma ( )
Neoplasm ( )
Osteosarcoma ( )
UniProt ID
DDX46_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
6Y50; 6Y53; 6Y5Q; 7EVO; 7Q3L; 7VPX
EC Number
3.6.4.13
Pfam ID
PF00270 ; PF00271
Sequence
MGRESRHYRKRSASRGRSGSRSRSRSPSDKRSKRGDDRRSRSRDRDRRRERSRSRDKRRS
RSRDRKRLRRSRSRERDRSRERRRSRSRDRRRSRSRSRGRRSRSSSPGNKSKKTENRSRS
KEKTDGGESSKEKKKDKDDKEDEKEKDAGNFDQNKLEEEMRKRKERVEKWREEQRKKAME
NIGELKKEIEEMKQGKKWSLEDDDDDEDDPAEAEKEGNEMEGEELDPLDAYMEEVKEEVK
KFNMRSVKGGGGNEKKSGPTVTKVVTVVTTKKAVVDSDKKKGELMENDQDAMEYSSEEEE
VDLQTALTGYQTKQRKLLEPVDHGKIEYEPFRKNFYVEVPELAKMSQEEVNVFRLEMEGI
TVKGKGCPKPIKSWVQCGISMKILNSLKKHGYEKPTPIQTQAIPAIMSGRDLIGIAKTGS
GKTIAFLLPMFRHIMDQRSLEEGEGPIAVIMTPTRELALQITKECKKFSKTLGLRVVCVY
GGTGISEQIAELKRGAEIIVCTPGRMIDMLAANSGRVTNLRRVTYVVLDEADRMFDMGFE
PQVMRIVDNVRPDRQTVMFSATFPRAMEALARRILSKPIEVQVGGRSVVCSDVEQQVIVI
EEEKKFLKLLELLGHYQESGSVIIFVDKQEHADGLLKDLMRASYPCMSLHGGIDQYDRDS
IINDFKNGTCKLLVATSVAARGLDVKHLILVVNYSCPNHYEDYVHRAGRTGRAGNKGYAY
TFITEDQARYAGDIIKALELSGTAVPPDLEKLWSDFKDQQKAEGKIIKKSSGFSGKGFKF
DETEQALANERKKLQKAALGLQDSDDEDAAVDIDEQIESMFNSKKRVKDMAAPGTSSVPA
PTAGNAEKLEIAKRLALRINAQKNLGIESQDVMQQATNAILRGGTILAPTVSAKTIAEQL
AEKINAKLNYVPLEKQEEERQDGGQNESFKRYEEELEINDFPQTARWKVTSKEALQRISE
YSEAAITIRGTYFPPGKEPKEGERKIYLAIESANELAVQKAKAEITRLIKEELIRLQNSY
QPTNKGRYKVL
Function
Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs. The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing. Within the 17S U2 SnRNP complex, DDX46 plays essential roles during assembly of pre-spliceosome and proofreading of the branch site.
KEGG Pathway
Spliceosome (hsa03040 )
Reactome Pathway
mRNA Splicing - Major Pathway (R-HSA-72163 )

Molecular Interaction Atlas (MIA) of This DOT

14 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 DIS84UUI Definitive Genetic Variation [1]
Amyotrophic lateral sclerosis type 4 DISSDHYG Strong Genetic Variation [2]
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [3]
Connective tissue disorder DISKXBS3 Strong Biomarker [4]
Esophageal squamous cell carcinoma DIS5N2GV Strong Altered Expression [5]
Hepatitis C virus infection DISQ0M8R Strong Genetic Variation [6]
Juvenile amyotrophic lateral sclerosis DISKDZC9 Strong Genetic Variation [2]
Systemic lupus erythematosus DISI1SZ7 Strong Biomarker [4]
Werner syndrome DISZY45W Strong Genetic Variation [7]
Small lymphocytic lymphoma DIS30POX moderate Altered Expression [8]
Systemic sclerosis DISF44L6 moderate Biomarker [7]
Bone osteosarcoma DIST1004 Limited Biomarker [9]
Neoplasm DISZKGEW Limited Biomarker [9]
Osteosarcoma DISLQ7E2 Limited Biomarker [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [10]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [11]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [12]
Cisplatin DMRHGI9 Approved Cisplatin affects the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [13]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [14]
Decitabine DMQL8XJ Approved Decitabine affects the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [13]
Cannabidiol DM0659E Approved Cannabidiol increases the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [15]
Clozapine DMFC71L Approved Clozapine increases the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [15]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Probable ATP-dependent RNA helicase DDX46 (DDX46). [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)
4 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
TAK-243 DM4GKV2 Phase 1 TAK-243 decreases the sumoylation of Probable ATP-dependent RNA helicase DDX46 (DDX46). [16]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 affects the phosphorylation of Probable ATP-dependent RNA helicase DDX46 (DDX46). [17]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Probable ATP-dependent RNA helicase DDX46 (DDX46). [18]
Coumarin DM0N8ZM Investigative Coumarin increases the phosphorylation of Probable ATP-dependent RNA helicase DDX46 (DDX46). [17]
------------------------------------------------------------------------------------

References

1 Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage.J Clin Neurosci. 2014 Sep;21(9):1627-31. doi: 10.1016/j.jocn.2013.11.048. Epub 2014 May 6.
2 DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet. 2004 Jun;74(6):1128-35. doi: 10.1086/421054. Epub 2004 Apr 21.
3 Lentiviral DDX46 knockdown inhibits growth and induces apoptosis in human colorectal cancer cells.Gene. 2015 Apr 15;560(2):237-44. doi: 10.1016/j.gene.2015.02.020. Epub 2015 Feb 11.
4 Autoantibodies to a nucleolar RNA helicase protein in patients with connective tissue diseases.Arthritis Rheum. 1997 Aug;40(8):1487-92. doi: 10.1002/1529-0131(199708)40:8<1487::AID-ART18>3.0.CO;2-P.
5 Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.Oncol Rep. 2016 Jul;36(1):223-30. doi: 10.3892/or.2016.4803. Epub 2016 May 11.
6 Induction of cell-mediated immune responses in mice by DNA vaccines that express hepatitis C virus NS3 mutants lacking serine protease and NTPase/RNA helicase activities.PLoS One. 2014 Jun 5;9(6):e98877. doi: 10.1371/journal.pone.0098877. eCollection 2014.
7 Werner's syndrome: from clinics to genetics.Clin Exp Rheumatol. 2000 Nov-Dec;18(6):760-6.
8 Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.PLoS One. 2016 Apr 14;11(4):e0148500. doi: 10.1371/journal.pone.0148500. eCollection 2016.
9 Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells.Oncol Res. 2017 Mar 13;25(3):417-425. doi: 10.3727/096504016X14747253292210. Epub 2016 Sep 30.
10 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
11 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
12 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
13 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
14 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
15 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
16 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
17 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
18 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
19 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.